TR199903283T2 - 5- (2-Ethyl-2H-Tetrazol-5-yl) -1-Methyl-1,2,3,6- Tetrahydropyridine maleate. - Google Patents

5- (2-Ethyl-2H-Tetrazol-5-yl) -1-Methyl-1,2,3,6- Tetrahydropyridine maleate.

Info

Publication number
TR199903283T2
TR199903283T2 TR1999/03283T TR9903283T TR199903283T2 TR 199903283 T2 TR199903283 T2 TR 199903283T2 TR 1999/03283 T TR1999/03283 T TR 1999/03283T TR 9903283 T TR9903283 T TR 9903283T TR 199903283 T2 TR199903283 T2 TR 199903283T2
Authority
TR
Turkey
Prior art keywords
tetrazol
ethyl
methyl
tetrahydropyridine
maleate
Prior art date
Application number
TR1999/03283T
Other languages
Turkish (tr)
Inventor
Bech Sommer Michael
Nielsen Ole
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of TR199903283T2 publication Critical patent/TR199903283T2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Mevcut bulus 5-(2-etil-2H-tetrazol-5-il) -1-metil-1,2,3,6- tetrahidropiridinin bir maleat asit ekleme tuzuyla, asit ekleme tuzunu içeren farmasötik kompozisyonlarla ve bunlarin asetilkolin (AcCh) veya muskarinik sistem fonksiyon bozuklugu kaynakli bozukluklarin tedavisinde kullanimiyla ilgilidir.The present invention 5- (2-ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine with a maleate acid addition salt, pharmaceutical compositions containing the acid addition salt, and their acetylcholine (AcCh) or muscarinic system is related to its use in the treatment of disorders caused by dysfunction.

TR1999/03283T 1997-07-01 1998-07-01 5- (2-Ethyl-2H-Tetrazol-5-yl) -1-Methyl-1,2,3,6- Tetrahydropyridine maleate. TR199903283T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
TR199903283T2 true TR199903283T2 (en) 2000-06-21

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03283T TR199903283T2 (en) 1997-07-01 1998-07-01 5- (2-Ethyl-2H-Tetrazol-5-yl) -1-Methyl-1,2,3,6- Tetrahydropyridine maleate.

Country Status (25)

Country Link
EP (1) EP0994869A1 (en)
JP (1) JP2002507215A (en)
KR (1) KR20010014297A (en)
CN (1) CN1261361A (en)
AR (1) AR013096A1 (en)
AU (1) AU735751B2 (en)
BG (1) BG103933A (en)
BR (1) BR9810331A (en)
CA (1) CA2293324A1 (en)
CO (1) CO4940483A1 (en)
EA (1) EA200000081A1 (en)
HU (1) HUP0002876A2 (en)
IL (1) IL133093A0 (en)
IS (1) IS5278A (en)
JO (1) JO2031B1 (en)
MA (1) MA25138A1 (en)
NO (1) NO996580L (en)
PE (1) PE116099A1 (en)
PL (1) PL337184A1 (en)
SK (1) SK187399A3 (en)
TN (1) TNSN98120A1 (en)
TR (1) TR199903283T2 (en)
UY (2) UY25069A1 (en)
WO (1) WO1999001448A1 (en)
ZA (1) ZA985498B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
TR199800801T2 (en) * 1995-11-06 1998-08-21 H. Lund-Beck A/S Treatment of traumatic brain injuries.

Also Published As

Publication number Publication date
PE116099A1 (en) 1999-11-23
JP2002507215A (en) 2002-03-05
CO4940483A1 (en) 2000-07-24
BG103933A (en) 2000-07-31
CA2293324A1 (en) 1999-01-14
IS5278A (en) 1999-11-30
AR013096A1 (en) 2000-12-13
SK187399A3 (en) 2000-06-12
NO996580D0 (en) 1999-12-30
HUP0002876A2 (en) 2001-06-28
CN1261361A (en) 2000-07-26
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
NO996580L (en) 1999-12-30
JO2031B1 (en) 1999-05-15
BR9810331A (en) 2000-09-05
MA25138A1 (en) 2001-04-02
PL337184A1 (en) 2000-08-14
EP0994869A1 (en) 2000-04-26
UY25069A1 (en) 1998-12-21
WO1999001448A1 (en) 1999-01-14
UY25177A1 (en) 2000-12-29
EA200000081A1 (en) 2000-08-28
ZA985498B (en) 1999-01-20
IL133093A0 (en) 2001-03-19
KR20010014297A (en) 2001-02-26
TNSN98120A1 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
DK274788A (en) tetrazoles
ATE199554T1 (en) COMPOSITIONS FOR DYEING KERATIN-CONTAINING FIBERS CONTAINING 3-AMINOPYRAZOLO-(1.5-A)-PYRIMIDINES, DYEING METHOD, 3-AMINOPYRAZOLO-(1.5-A)-PYRIMIDINES AND THEIR PRODUCTION
PT1274687E (en) 1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES
TR200101499T1 (en) Azepinoindole derivatives, their preparation and uses.
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
DE3751045D1 (en) Pacemakers controlled by the rhythm.
CA2297911A1 (en) Substituted 6-phenylphenanthridines
ATE416772T1 (en) BIPHENYLSULFONAMIDE AS DUALLY ACTIVE RECEPTOR ANTAGONISTS OF ANGIOTENSIN AND ENDOTHELIN
DE19775083I2 (en) 7-piperazinyl or 7-morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
FR2791684B1 (en) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING THE TRIPEPTIDE N-N-BIOTINYL-GLY-HIS-LYS FOR PREVENTING, REDUCING OR SUPPRESSING HAIR LOSS AS WELL AS TO PROMOTE THEIR GROWTH
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
NO20002702L (en) thienopyrimidine
PT615751E (en) UTILIZATION OF TAQUININE ANTAGONISTS IN EMESE TREATMENT
KR100292396B1 (en)
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
TR199903283T2 (en) 5- (2-Ethyl-2H-Tetrazol-5-yl) -1-Methyl-1,2,3,6- Tetrahydropyridine maleate.
DK52685D0 (en) N, 3-DIACYL-2-OXINDOL-1-CARBOXAMIDE COMPOUNDS AND INTERMEDIATES IN THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS
DK228687A (en) 2-PYRIDYL-PENEM COMPOUNDS AND SALTS THEREOF AND THEIR PREPARATION AND USE
TR200002939T2 (en) Paroxetine maleate
ZW6789A1 (en) &-adrenergic receptor antagonists
MX12192A (en) PHARMACEUTICAL COMPOSITION TO REDUCE OR PREVENT ARRHYTHMIAS
ZW6889A1 (en) &-adrenergic receptor antagonists
FI905922A0 (en) ANTAGONISTER FOER A-ADRENERGA RECEPTORER.
UA43797A (en) Injection form of the preparation, which manifests the anti-ischemic activity